Acute myeloid leukemia: open trials in Belgium

27 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven
Registry updated 2026-11-06
NCT07223814
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Antwerpen, Edegem · Ziekenhuis Geel, Geel · Universitair Ziekenhuis Gent, Gent · JESSA Ziekenhuis, Hasselt · Chu Helora, La Louvière · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-11-06
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-11-04
NCT04628026
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
Trial Treatment · Phase 3 · University of Ulm
Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Universitair Ziekenhuis Brussel, Brussel · Katholieke Universiteit te Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · CHU UCL NAMUR - Mont Godinne, Yvoir
Registry updated 2026-11-03
NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
AZ Sint Jan, Bruges · UZ Antwerpen, Edegem · Ziekenhuis Oost-Limburg, Genk · Ghent university hospital, Ghent · Chu Helora Hospital La Louviere Site Jolimont, La Louvière · Universitair Ziekenhuis Leuven, Leuven · Clinique Saint Pierre, Ottignies · Algemeen Ziekenhuis Delta, Roeselare
Registry updated 2026-11-03
2024-512753-24-00
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.
Trial Treatment · Phase 3 · Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-10-21
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-21
2023-506546-23-00
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven
Registry updated 2026-10-16
NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Trial Treatment · Phase 3 · Kura Oncology, Inc.
Az St-Jan Brugge-Oostende A.V., Brugge · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · Centre Hospitalier Universitaire de Liège, Liège · Algemeen Ziekenhuis Delta, Roeselare · CHR Verviers, Verviers
Registry updated 2026-10-13
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Ghent university hospital, Ghent
Registry updated 2026-10-09
2023-504999-25-00
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-23
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
CHU de Liège, Liège
Registry updated 2026-09-15
NCT06652438
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-09-02
NCT06788756
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Trial Treatment · Phase 2/3 · Moleculin Biotech, Inc.
Institut Jules Bordet, Anderlecht
Registry updated 2026-08-05
2024-520125-36-00
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 1 · AbbVie Deutschland GmbH & Co. KG
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-07-22
2023-504555-27-00
Study comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid leukemia or myelodysplastic syndrome and receiving an allogeneic stem cell transplantation with an unrelated matched donor after a reduced intensity conditioning regimen
Trial Treatment · Phase 3 · Assistance Publique Hopitaux De Paris
Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-07-15
NCT05907057
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Trial Treatment · Phase 3 · Servier Affaires Médicales
Het Ziekenhuisnetwerk Antwerpen, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Institut Jules Bordet, Brussels · Universitair Ziekenhuis Gent, Gent · JESSA Ziekenhuis, Hasselt · Pôle Hospitalier Jolimont, La Louvière · UZ Leuven, Leuven · CHU de Liège, Liège · AZ Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-05-08
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
ZNA Cadix, Antwerp · UZ Ghent, Ghent · University Hospitals Leuven, Leuven · AZ Delta, Roeselare
Registry updated 2026-03-24
NCT03828773
PTX3-targeted Antifungal Prophylaxis
Trial Treatment · Phase 4 · Bochud Pierre-Yves
UZ Gent, Gent · UZ Leuven, Leuven · AZ Sint-Jan Brugge-Oostende AV
Registry updated 2025-12-09
NCT07075016
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
BE-Antwerpen-ZAS, Antwerp · BE-Brussel-UZBRUSSEL, Brussels · BE-Bruxelles-STLUC, Brussels · BE-Brussel-BORDET, Brussels · BE-Gent-UZGENT, Ghent · BE-Leuven-UZLEUVEN, Leuven · BE-Liege-CHULIEGE, Liège · BE-Yvoir-MONTGODINNE, Yvoir
Registry updated 2025-08-19
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Trial Treatment · Phase 2 · Princess Maxima Center for Pediatric Oncology
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2025-08-05
NCT05477589
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Trial Treatment · Phase 3 · Vastra Gotaland Region
Cliniques Universitaires Saint-Luc (CUSL), Brussels · L'Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels · Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital, Ghent · University Hospital Leuven, Leuven · Centre Hospitalier Régional de la Citadelle (CHR)/CHU Liège, Liège
Registry updated 2024-12-19
NCT01828489
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
Trial Treatment · Phase 3 · Vaestra Goetalandsregionen
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2024-11-22
NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Trial Treatment · Phase 2 · Associazione Italiana Ematologia Oncologia Pediatrica
Hôpital Universitaire des Enfants Reine Fabiola (Huderf), Brussels
Registry updated 2024-04-15
NCT03852407
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Trial Treatment · Phase 2 · University of Liege
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Universiteit Gent, Gent · Vrije Universiteit Brussel, Jette · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2022-10-12

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error